CLINICAL_TRIALS
trial_result
· 2021-11-09
Clinical Trial Update: Exploratory Study on Dosage of Qizhi Weitong Granules in the Treatment of Irritable Bowel Syndrome (IBS) [Phase 2]
Summary
Phase 2 exploratory study evaluating dosage of Qizhi Weitong Granules for Irritable Bowel Syndrome.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. | Conditions: Irritable Bowel Syndrome | Phase 2 | Status: UNKNOWN